News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Asabys Partners
Augustine Therapeutics raises EUR 17 million in a series a first closing to advance lead candidate into clinical development in neurological diseases
Healthcare · Access to innovation · Financing
Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6…
Partners - Asabys Partners
Oryzon_AseBio
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
Corporate
All resolutions were approved. Additional resolution to increase capital for up to 100 million…
Partners - Oryzon Genomics
Profesional de laboratorio manipulando máquinas en la instalaciones de Hipra
The European authority HERA visits HIPRA for its productive capacity in the face of future pandemic
Healthcare · Access to innovation · Drug discovery · Industrial biotechnology
The top leadership team from HERA (Health Emergency Preparedness and Response), the European…
Partners - HIPRA HUMAN HEALTH S.L.U.
Una chica apoyada en una pared
Oryzon announces presentation of final data from PORTICO, vafidemstat’s global Phase IIb trial in Borderline Personality Disorder, at the 37th ECNP annual conference
Healthcare · Access to innovation · Rare diseases · Advanced therapies
Seleccionada para presentación oral. La conferencia se celebrará en Milán del 21-23 de septiembre…
Partners - Oryzon Genomics
Investigación en biotecnología
Overcoming Challenges in the Current Biotech Landscape
Biotech entrepreneurs have experienced a demanding drug development environment in the last 24…
foto_recurso_medicamentos
Alira Health Publishes a White Paper on the Impact of New European Union Regulations on Advanced Therapy Medicinal Product
Healthcare · Access to innovation · Drug discovery
It provides an overview of the key changes that will impact access to innovative medicines and…
células foto oryzon
ORYZON presents preliminary data from ongoing Phase Ib FRIDA trial with iadademstat plus gilteritinib in relapsed/refractory FLT3-mut AML patients at EHA-2024
Healthcare · Access to innovation · Drug discovery · Rare diseases
Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was…
Partners - Oryzon Genomics
Andrea Zapater, especialista en Producto Bio de Paralab Bio
#NewAseBioMember | “AseBio represents an essential platform for collaboration, networking and growth in the biotechnology sector”
Corporate
Meet Paralab Bio, our new member. We talked to its Andrea Zapater, Bio Product Specialist.
Partners - PARALAB
Rafael Simó
Rafael Simó: "We should talk about "obesities" instead of "obesity" because more and more phenotypes are described, in which genetic, metabolic, environmental, socio-cultural and mental health factors combine in different ways"
Healthcare · Access to innovation · Drug discovery
Geneis Biomed interviews Dr. Rafael Simón, head of the Endocrinology and Nutrition Department at…
Partners - GENESIS Biomed